Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Intraductal, Noninfiltrating | 18 | 2024 | 926 | 7.410 |
Why?
|
Mammography | 36 | 2024 | 2430 | 6.940 |
Why?
|
Breast Neoplasms | 52 | 2024 | 21012 | 4.810 |
Why?
|
Carcinoma, Ductal, Breast | 11 | 2023 | 1085 | 4.640 |
Why?
|
Breast | 22 | 2024 | 1967 | 3.630 |
Why?
|
Artificial Intelligence | 10 | 2024 | 2578 | 2.680 |
Why?
|
Ultrasonography, Mammary | 5 | 2024 | 239 | 2.340 |
Why?
|
Carcinoma in Situ | 5 | 2023 | 791 | 2.070 |
Why?
|
Carcinoma, Lobular | 3 | 2023 | 481 | 1.840 |
Why?
|
Nipples | 4 | 2016 | 229 | 1.450 |
Why?
|
Early Detection of Cancer | 15 | 2024 | 3201 | 1.350 |
Why?
|
Four-Dimensional Computed Tomography | 4 | 2019 | 141 | 1.260 |
Why?
|
Watchful Waiting | 4 | 2020 | 491 | 1.250 |
Why?
|
Parathyroid Neoplasms | 3 | 2019 | 242 | 1.120 |
Why?
|
Thyroid Nodule | 5 | 2018 | 764 | 1.050 |
Why?
|
Mastectomy, Segmental | 5 | 2023 | 955 | 1.000 |
Why?
|
Preoperative Care | 3 | 2020 | 2242 | 1.000 |
Why?
|
Exudates and Transudates | 2 | 2016 | 174 | 0.990 |
Why?
|
Precancerous Conditions | 2 | 2023 | 980 | 0.900 |
Why?
|
Thyroid Neoplasms | 6 | 2018 | 2332 | 0.880 |
Why?
|
Calcinosis | 2 | 2023 | 1469 | 0.870 |
Why?
|
Fibrocystic Breast Disease | 1 | 2022 | 103 | 0.770 |
Why?
|
Writing | 1 | 2023 | 199 | 0.760 |
Why?
|
Review Literature as Topic | 1 | 2023 | 348 | 0.740 |
Why?
|
Retrospective Studies | 39 | 2024 | 80636 | 0.740 |
Why?
|
Cicatrix | 2 | 2024 | 798 | 0.730 |
Why?
|
Radiology | 3 | 2024 | 2113 | 0.730 |
Why?
|
Sensitivity and Specificity | 11 | 2024 | 14666 | 0.720 |
Why?
|
Radiographic Image Enhancement | 3 | 2023 | 876 | 0.680 |
Why?
|
Magnetic Resonance Imaging | 13 | 2024 | 36426 | 0.660 |
Why?
|
Choristoma | 1 | 2020 | 206 | 0.640 |
Why?
|
Hyperparathyroidism, Primary | 2 | 2019 | 163 | 0.640 |
Why?
|
Unnecessary Procedures | 3 | 2021 | 415 | 0.630 |
Why?
|
Incidental Findings | 5 | 2018 | 697 | 0.610 |
Why?
|
Gadolinium | 1 | 2023 | 960 | 0.600 |
Why?
|
Mass Screening | 5 | 2023 | 5428 | 0.580 |
Why?
|
Female | 60 | 2024 | 392644 | 0.580 |
Why?
|
Aged | 39 | 2024 | 169289 | 0.570 |
Why?
|
Parathyroid Glands | 1 | 2019 | 518 | 0.560 |
Why?
|
Triage | 1 | 2024 | 986 | 0.550 |
Why?
|
Middle Aged | 42 | 2024 | 220895 | 0.550 |
Why?
|
Adenoma | 2 | 2019 | 2160 | 0.540 |
Why?
|
Aged, 80 and over | 22 | 2023 | 58976 | 0.530 |
Why?
|
Biopsy, Needle | 2 | 2018 | 1626 | 0.520 |
Why?
|
Mastectomy, Subcutaneous | 1 | 2016 | 56 | 0.520 |
Why?
|
Disease Notification | 1 | 2016 | 95 | 0.510 |
Why?
|
Humans | 74 | 2024 | 761504 | 0.500 |
Why?
|
Adult | 33 | 2024 | 221177 | 0.430 |
Why?
|
Neoplasms, Second Primary | 1 | 2020 | 1052 | 0.400 |
Why?
|
Contrast Media | 3 | 2023 | 5311 | 0.400 |
Why?
|
Neoplasm Staging | 4 | 2024 | 11121 | 0.360 |
Why?
|
Diagnostic Imaging | 2 | 2022 | 3530 | 0.350 |
Why?
|
Imaging, Three-Dimensional | 2 | 2020 | 4063 | 0.340 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2020 | 1727 | 0.330 |
Why?
|
Evidence-Based Medicine | 1 | 2021 | 3688 | 0.330 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 5 | 2024 | 1222 | 0.320 |
Why?
|
Thyroid Gland | 1 | 2014 | 1168 | 0.300 |
Why?
|
Ischemia | 1 | 2016 | 1882 | 0.290 |
Why?
|
Hyperplasia | 2 | 2023 | 1152 | 0.270 |
Why?
|
Neoplasm Invasiveness | 3 | 2020 | 3595 | 0.270 |
Why?
|
Carcinoma | 1 | 2017 | 2330 | 0.260 |
Why?
|
Thyroidectomy | 3 | 2017 | 907 | 0.250 |
Why?
|
Risk | 4 | 2021 | 9610 | 0.240 |
Why?
|
Benchmarking | 2 | 2023 | 1045 | 0.230 |
Why?
|
Mastectomy | 2 | 2023 | 1822 | 0.230 |
Why?
|
Reproducibility of Results | 6 | 2024 | 20098 | 0.230 |
Why?
|
Intra-Abdominal Fat | 1 | 2008 | 613 | 0.220 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 5368 | 0.210 |
Why?
|
Skin | 1 | 2016 | 4484 | 0.200 |
Why?
|
Fatty Liver | 1 | 2008 | 790 | 0.200 |
Why?
|
Nomograms | 1 | 2023 | 230 | 0.190 |
Why?
|
Risk Assessment | 6 | 2024 | 23995 | 0.190 |
Why?
|
Biopsy | 3 | 2020 | 6766 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9280 | 0.170 |
Why?
|
Radiology Information Systems | 1 | 2024 | 529 | 0.170 |
Why?
|
Health Literacy | 1 | 2024 | 444 | 0.150 |
Why?
|
Adenocarcinoma | 1 | 2015 | 6346 | 0.150 |
Why?
|
Wireless Technology | 1 | 2018 | 98 | 0.150 |
Why?
|
Fiducial Markers | 1 | 2018 | 132 | 0.140 |
Why?
|
North Carolina | 2 | 2014 | 325 | 0.130 |
Why?
|
Predictive Value of Tests | 3 | 2019 | 15266 | 0.130 |
Why?
|
Parathyroid Diseases | 1 | 2016 | 46 | 0.130 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39106 | 0.130 |
Why?
|
United States | 6 | 2020 | 72334 | 0.130 |
Why?
|
Magnetics | 1 | 2018 | 599 | 0.120 |
Why?
|
Needles | 1 | 2018 | 451 | 0.120 |
Why?
|
Radionuclide Imaging | 1 | 2019 | 1972 | 0.120 |
Why?
|
Iopamidol | 1 | 2015 | 186 | 0.120 |
Why?
|
Ultrasonography | 3 | 2019 | 5972 | 0.120 |
Why?
|
Postoperative Complications | 2 | 2017 | 15631 | 0.120 |
Why?
|
Prognosis | 3 | 2023 | 29625 | 0.120 |
Why?
|
Lung Neoplasms | 1 | 2018 | 13380 | 0.110 |
Why?
|
Liver | 1 | 2008 | 7529 | 0.100 |
Why?
|
Single-Blind Method | 1 | 2016 | 1572 | 0.100 |
Why?
|
Ultrasonography, Doppler | 1 | 2014 | 462 | 0.100 |
Why?
|
Radiography | 1 | 2023 | 6965 | 0.100 |
Why?
|
Biopsy, Fine-Needle | 2 | 2014 | 1118 | 0.100 |
Why?
|
Necrosis | 1 | 2016 | 1611 | 0.100 |
Why?
|
Carcinoma, Papillary | 1 | 2017 | 785 | 0.100 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2024 | 3357 | 0.100 |
Why?
|
Diagnostic Errors | 2 | 2016 | 1265 | 0.090 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 1068 | 0.090 |
Why?
|
Radiography, Interventional | 1 | 2018 | 1121 | 0.090 |
Why?
|
Recurrence | 1 | 2023 | 8465 | 0.090 |
Why?
|
Lymphatic Metastasis | 1 | 2018 | 2915 | 0.090 |
Why?
|
Prevalence | 3 | 2018 | 15732 | 0.090 |
Why?
|
Ultrasonography, Interventional | 1 | 2018 | 1496 | 0.090 |
Why?
|
Reoperation | 1 | 2020 | 4303 | 0.090 |
Why?
|
Sex Distribution | 1 | 2014 | 2281 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2014 | 2927 | 0.080 |
Why?
|
Age Distribution | 1 | 2014 | 2880 | 0.080 |
Why?
|
Odds Ratio | 1 | 2020 | 9646 | 0.080 |
Why?
|
Risk Factors | 4 | 2021 | 74206 | 0.080 |
Why?
|
Logistic Models | 1 | 2022 | 13255 | 0.070 |
Why?
|
Young Adult | 4 | 2018 | 59243 | 0.070 |
Why?
|
Guideline Adherence | 2 | 2014 | 2220 | 0.070 |
Why?
|
Male | 10 | 2019 | 360804 | 0.070 |
Why?
|
Age Factors | 1 | 2022 | 18395 | 0.060 |
Why?
|
Cohort Studies | 2 | 2020 | 41487 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20570 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2014 | 2759 | 0.060 |
Why?
|
Adolescent | 5 | 2015 | 88319 | 0.050 |
Why?
|
Medical Oncology | 1 | 2014 | 2321 | 0.050 |
Why?
|
Positron-Emission Tomography | 2 | 2014 | 6485 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12059 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11076 | 0.040 |
Why?
|
Program Evaluation | 2 | 2018 | 2495 | 0.040 |
Why?
|
Child, Preschool | 1 | 2022 | 42230 | 0.040 |
Why?
|
Hepatitis C | 1 | 2008 | 1584 | 0.040 |
Why?
|
Feedback | 1 | 2020 | 791 | 0.030 |
Why?
|
Incidence | 1 | 2014 | 21353 | 0.030 |
Why?
|
Parathyroidectomy | 1 | 2016 | 242 | 0.030 |
Why?
|
Patient-Centered Care | 1 | 2024 | 1421 | 0.030 |
Why?
|
Tumor Burden | 1 | 2017 | 1893 | 0.020 |
Why?
|
Body Mass Index | 1 | 2008 | 12953 | 0.020 |
Why?
|
Prospective Studies | 2 | 2020 | 54425 | 0.020 |
Why?
|
Equipment Design | 1 | 2018 | 3510 | 0.020 |
Why?
|
Workload | 1 | 2014 | 844 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2014 | 64680 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5247 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2016 | 2651 | 0.020 |
Why?
|
Child | 2 | 2014 | 80153 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7967 | 0.010 |
Why?
|
HIV Infections | 1 | 2008 | 17351 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12974 | 0.010 |
Why?
|
Algorithms | 1 | 2018 | 14031 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7390 | 0.010 |
Why?
|
Concepts
(147)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_